Fig. 5From: MicroRNA-22-3p ameliorates Alzheimer’s disease by targeting SOX9 through the NF-κB signaling pathway in the hippocampusResults of HE (A), Nissl (B), and immunohistochemical (C) stainings and the statistics of immunohistochemical staining (D) of Aβ. *P < 0.05, n = 3Back to article page